Patient | Type of LVAD | Admission Plt (K/uL) | Temporal Plt nadir (K/uL)* | ELISA OD | 4-T probability** | Heme-onc consult | SRA*** | HITTST | Time of heparin exposure prior to LVAD surgery (days)TT | Time between heparin exposure and HIT Ab + (days) |
---|---|---|---|---|---|---|---|---|---|---|
1 | Heartmate II | 157 | 127 | 0.54 | Low | Y | (-) | No | 12 | 19 |
2 | Heartmate II | 120 | 80 | 0.82 | Intermed | N | n/a | No | n/a | 0t |
3 | Heartware | 203 | 99 | 0.44 | Intermed | Y | n/a | DVT | 17 | 21 |
4 | Heartware | 217 | 118 | 0.64 | Low | N | (-) | No | 6 | 10 |
5 | Heartmate II | 166 | 102 | 0.63 | Low | N | n/a | No | n/aTTT | 6 |
6 | Heartmate II | 218 | 30 | 0.45 | Intermed | Y | n/a | No | 9 | 8 |
7 | Heartmate II | 42 | 16 | 0.63 | Low | Y | (-) | DVT, PE, stroke | 13 | 1t |
8 | Heartmate II | 526 | 45 | 3.15 | High | Y | (+) | PE | 5 | 5 |